Last update 04 Nov 2024

Bevantolol Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(±)-bevantolol, 1-((2-(3,4-dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol, 1-(3,4-dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol
+ [17]
Mechanism
ADRA1 antagonists(Adrenergic receptor alpha-1 antagonists), Cav2.2 blockers(Voltage-gated N-type calcium channel alpha-1B subunit blockers), VMAT2 inhibitors(Synaptic vesicular amine transporter inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
JP (31 Mar 1995),
RegulationOrphan Drug (US)
Login to view timeline

Structure

Molecular FormulaC20H28ClNO4
InChIKeyFJTKCFSPYUMXJB-UHFFFAOYSA-N
CAS Registry42864-78-8

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hypertension
JP
31 Mar 1995
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Huntington DiseasePhase 2
ES
08 Aug 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
32
sfaszgehnk(lzfwpdnoyj) = The most frequent adverse events during SOM3355 administration were mild to moderate zqanlntimm (zjcfrugdlv )
-
09 Dec 2022
Phase 2
32
pwzwhzjecz(nlmpyykinl) = yooggobgyn iwagmewrdf (peldbfrqxe )
Positive
04 Oct 2021
Placebo
-
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free